Clario

Clario is a leading healthcare research and technology company that generates the richest clinical evidence in the industry for their pharmaceutical, biotech and medical device partners. Across decentralized, hybrid and site-based trials, their deep scientific expertise, global scale and the broadest endpoint technology platform in the industry allows their partners to transform lives.

Case Studies

Showing 22 Clario Customer Success Stories

search button

Digital health program drives better medication and lifestyle management for COPD patients

AstraZeneca logo

Scientific experts at Clario helped a sponsor address concerns about the way its initial eCOA solution handled the collection of Adverse Event information

Clario simplifies complex eCOA and imaging GI study with single-vendor solution

Global biotech gains visibility into treatment-related risk of SIB Clario’s exclusive patient-reported eC-SSRS rapidly detected suicidal ideation and behavior

Global pharma company ramped up enrollment by integrating participation into everyday life

Global pharmaceutical company proves efficacy of bronchodilator for COPD patients

Clario supports accelerated FDA approval in non-small cell lung cancer study

Clario Safety & Efficacy Solutions integrated with Enhanced Business Intelligence helps secure new drug approval from global regulatory authorities

Global, publicly traded company chooses Clario CTMS to manage its clinical studies

Target my hives a digital community bringing patients together

Training Program Reduces Placebo Effect By More Than 50% In Epro Study

Reduce the Time to Implement Your Clinical Trial Management System With Bioclinica CTMS

Simple effectiveness study deploys electronic data capture solution despite tight timelines

Clario supports large pharmaceutical company with a complex Alzheimer’s disease study

Global pharmaceutical company drives data acceptability over 95%

Clario delivers study setup in 10 weeks for a global chronic weight management study

Collaborative data management activities to prepare six years of data for submission

High-quality compliant eCOA data captured across group of oncology studies

Major pharma company eases data collection and maintains patient participation during a 2 1⁄2 year dermatitis study

Merck Research Laboratories Reduces Standard Deviation With Electronic Pro

Merck logo

Clario helps establish the cardiac safety profile of a novel oncologic in early phase

Vaccine developer achieves cost-effective and streamlined transition to electronic data capture

No matching case studies